We report a patient with AL amyloidosis and chemo-resistant light-chain multiple myeloma who developed a progressive malignant pericardial effusion leading to cardiac tamponade. Despite pericardiocentesis and surgical intervention, the pericardial effusion failed to resolve. The administration of oral colchicine produced symptomatic relief within 5 days, with the resolution of pericardial effusion after 14 days of treatment. As the administration of colchicine is simple and the side-effect is usually minimal, further studies are warranted to establish the feasibility of using colchicine to treat malignant pericardial effusion.

Keywords:
Cardiac tamponade, Colchicine, Malignant pericardial effusion, Multiple myeloma
1.
Cohen GU, Peery TM, Evans JM: Neoplastic invasion of the heart and pericardium. Ann Intern Med 1955;42:1238–1245.
2.
Guberman BA, Fowler NO, Engel PJ, Gueron M, Allen JM: Cardiac tamponade in medical patients. Circulation 1981;64:633–640.
3.
Cham WC, Freiman AG, Carstens HB, Chu FCH: Radiation therapy of cardiac and pericardial metastases. Radiology 1975;114:701–704.
4.
Martini N, Freiman AH, Watson RC, Hilaris BS: Intrapericardial instillation of radioactive chronic phosphate in malignant pericardial effusion. Am J Roentgenol 1977;128:639–641.
5.
Shephard FA, Ginsbery JS, Evans WK, Scott JG, Oleksuik F: Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 1985;3:1678–1682.
6.
Van der Gaast A, Kok TC, van der Linden NH, Splinter TA: Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 1989;25:1505–1506.
7.
Colleoni M, Martinelli G, Beretta F, Marone C, Gallino A, Fontana M, Graffeo R, Zampino G, De Pas T, Cipolla G, Martinoni C, Goldhirsch A: Intracavitary chemotherapy with thiotepa in malignant pericardial effusion: An active and well-tolerated regime. J Clin Oncol 1998;16:2371–2376.
8.
Hankins JR, Satterfield JR, Aisner J, Wiernik PH, McLaughlin JS: Pericardial window for malignant pericardial effusion. Ann Thorac Surg 1980;30:465–471.
9.
Rosenbaum H, Hoffman R, Carter A, Brenner B, Markel A, Ben-Arie Y, Rowe JM: Multiple myeloma with pericardial involvement and cardiac tamponade: A report of three patients. Leuk Lymphoma 1996;24:183–186.
10.
Ben-Chetrit E, Levy M: Colchicine: 1998 Update. Semin Arthritis Rheum 1998;28:48–59.
11.
Fernandez-Muixi J, Vidal F, Bardaji A, Richart C: Recurrent pericarditis and cardiac tamponade in rheumatoid arthritis: Effectiveness of colchicine. Br J Rheumatol 1994;33:596–597.
12.
Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes-Genis A, Sagie A, Bayes de Luna A, Spodick DH: Colchicine treatment for recurrent pericarditis: A decade of experience. Circulation 1998;97:2183–2185.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.